Assembly Biosciences ASMB
NASDAQ ASMB
$23.48 -0.13 (-0.55%)
At close: Sep 29, 2026 · 4:00 PM EDT

Assembly Biosciences (ASMB) Total Debt (2010 - 2011)

Updated

Assembly Biosciences (ASMB) recorded Total Debt of $1.32 million in Q2 2011.

Analysis

Assembly Biosciences (ASMB) Total Debt (2010 - 2011) Analysis & Trends

At the end of FY2010, Assembly Biosciences reported Total Debt of $2.49 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 49.04 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 70.82 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 53.91 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 37.49 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -111.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 57.30 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 26.25 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 63.19 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Assembly Biosciences 468.67 Mn -558.96 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2011 1.32 Mn
Dec 31, 2010 2.49 Mn
API Access

Assembly Biosciences Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=ASMB&period=max&api_key=YOUR_API_KEY